Peptomyc
PrivateLast Round
VC Round
Mar 24, 2024
Total Funding Raised
$24.69M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Peptomyc operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a VC Round in March 2024.
Peptomyc is a biotechnology company developing a new generation of cell-penetrating peptide therapeutics targeting the MYC oncogene for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptomyc Comparables
Compare Peptomyc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Incurix | 77% | |
| Omega Therapeutics | 77% | |
| Racura Oncology Ltd | 77% |
For institutional investors. Book with your work email.
Peptomyc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 24, 2024 | ||||
| Grant | Oct 31, 2023 | ||||
| Convertible Debt | Jan 20, 2022 | ||||
| VC Round | Dec 15, 2020 | ||||
| Series A | Sep 12, 2019 | ||||
Grant | Jul 30, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Peptomyc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Convertible Debt |
| European Union's Horizon Research and Innovation program | Grant |
| European Innovation Council Fund | VC Round, Grant |
| Alta Life Sciences | Convertible Debt, VC Round, Series A |
| Healthequity SCR | Convertible Debt, VC Round, Series A, Seed |
| Agencia Estatal de Investigación | Debt |
| EIT Health | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 41% MoM.
- Jul 26, 2026
Monthly visitors increased 39% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 29, 2026
On Sep 29th '26 in Spain, Peptomyc completes its equity financing round with participation from ICF, Asabys, Aurora Science, the EIC Fund, Laudecum and CDTI to fund OMO-103 clinical studies, manufacturing readiness and pharmaceutical partnership discussions.
- receives_financingSep 29, 2026
Peptomyc receives $782K in equity financing in Spain on Sep 29th '26
For institutional investors. Book with your work email.
Peptomyc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Peptomyc's valuation, stock price, and market status.
Is Peptomyc a public or private company?
Peptomyc is a private company.
What is the current stock price of Peptomyc?
Peptomyc is a private company, so its shares have no public market price. Caplight tracks Peptomyc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Peptomyc worth (valuation)?
Valuation information for Peptomyc is not publicly available.
Can I buy Peptomyc stock?
Peptomyc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Peptomyc's last funding round?
Peptomyc's most recent funding round was VC Round on March 24, 2024.
Who are the main investors in Peptomyc?
Key investors in Peptomyc include European Union's Horizon Research and Innovation program, European Innovation Council Fund, Alta Life Sciences, Healthequity SCR, EIT Health.
Will Peptomyc IPO soon?
No public IPO plans have been announced for Peptomyc.
How can I track Peptomyc secondary market activity?
Caplight tracks bids, offers, and trades in Peptomyc's shares on secondary markets.